Research Topics
| Matthew RutterSummaryAffiliation: University Hospital of North Tees Country: UK Publications
| Collaborators
|
Detail Information
Publications
Surveillance programmes for neoplasia in colitisMatthew D Rutter
Tees Bowel Cancer Screening Centre, University Hospital of North Tees, Stockton on Tees, Cleveland, TS19 8PE, UK
J Gastroenterol 46:1-5. 2011..It is hoped that such developments will further improve the effectiveness of colitis surveillance...
Intangible costs and benefits of ulcerative colitis surveillance: a patient surveyMatthew D Rutter
University Hospital of North Tees, Stockton on Tees, Cleveland, United Kingdom
Dis Colon Rectum 49:1177-83. 2006..Colonoscopic surveillance in ulcerative colitis has costs and benefits beyond cancer prevention, which might influence program efficacy. This study assesses the more intangible aspects of surveillance...
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitisMatthew D Rutter
Department of Gastroenterology, University Hospital of North Tees, Stockton on Tees, Teesside, England
Gastroenterology 130:1030-8. 2006..The value of colonoscopic surveillance for neoplasia in long-standing extensive ulcerative colitis remains controversial. This study reports on prospectively collected data from a surveillance program over a 30-year period...
Endoscopic appearance of dysplasia in ulcerative colitis and the role of stainingM Rutter
University Hospital of North Tees, Hardwick, Stockton-on-Tees, Teesside, UK
Endoscopy 36:1109-14. 2004
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer riskM D Rutter
University Hospital of North Tees, Stockton on Tees, Teesside TS19 8PE, UK
Gut 53:1813-6. 2004..The risk of colorectal cancer is increased in ulcerative colitis (UC). Patients with UC have diverse colonoscopic appearances. Determining colonoscopic markers for cancer risk could allow patient risk stratification...
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisMatthew Rutter
Department of Gastroenterology, University Hospital of North Tees, Stockton on Tees, Teesside, England
Gastroenterology 126:451-9. 2004..Patients with ulcerative colitis are at increased risk of colorectal cancer. It is widely believed that this is secondary to colonic inflammation. However, the severity of colonic inflammation has never been shown to be a risk factor...
Most dysplasia in ulcerative colitis is visible at colonoscopyMatthew D Rutter
St Mark's Hospital, Harrow, London, United Kingdom
Gastrointest Endosc 60:334-9. 2004..From a clinical perspective, the endoscopic resectability of a lesion is more important than whether it is thought to be a sporadic adenoma or a dysplasia-associated lesion/mass...
A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's stricturesJames E East
Wolfson Unit for Endoscopy, St Mark s Hospital, Harrow, Middlesex, United Kingdom
Clin Gastroenterol Hepatol 5:1065-9. 2007..Intrastricture steroid injection after balloon dilatation has been reported to reduce the need for repeat dilatation in retrospective series, but no randomized data are available...
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and updateDavid T Rubin
University of Chicago Medical Center, Chicago, IL 60637, USA
Inflamm Bowel Dis 14:265-74. 2008..This article provides a comprehensive overview of the issues discussed and should act as a guide to shaping the design of future studies in this area...
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?Matthew D Rutter
Gastrointest Endosc 67:1009; author reply 1009-10. 2008
Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapyRoberto Zinicola
Wolfson Unit for Endoscopy, St. Mark's Hospital, Watford Road, Harrow, HA1 3UJ, UK
Int J Colorectal Dis 18:439-44. 2003..Endoscopic severity of haemorrhagic radiation proctitis may be useful to guide appropriate therapy...
